Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session II: Lymphoma II
New Developments in Waldenstrom’s Macroglobulinemia
Friday, April 22, 2022
11:20 AM – 11:40 AM
Speaker(s)
Jorge J. Castillo, MD
Associate Professor
Harvard Medical School
Boston, Massachusetts
Learning Objectives:
Recount the genomic landscape of WM and how it will impact patient care
Summarize key clinical data for the BTK inhibitor approved for the treatment of WM
Describe clinical indications that a patient with WM requires treatment